{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Phase Ia, first in human open label, dose escalation trial evaluating intravenous BI 1703880 in combination with intravenous ezabenlimab for treatment of advanced solid tumours","item":"https:\/\/www.regionalcancercare.org\/trials\/phase-ia-first-in-human-open-label-dose-escalation-trial-evaluating-intravenous-bi-1703880-in-combination-with-intravenous-ezabenlimab-for-treatment-of-advanced-solid-tumours\/#breadcrumbitem"}]}